NO20063522L - Gastrointestinal proliferativ faktor og anvendelser derav - Google Patents
Gastrointestinal proliferativ faktor og anvendelser deravInfo
- Publication number
- NO20063522L NO20063522L NO20063522A NO20063522A NO20063522L NO 20063522 L NO20063522 L NO 20063522L NO 20063522 A NO20063522 A NO 20063522A NO 20063522 A NO20063522 A NO 20063522A NO 20063522 L NO20063522 L NO 20063522L
- Authority
- NO
- Norway
- Prior art keywords
- proliferative factor
- gastrointestinal
- gastrointestinal proliferative
- gipf
- factor
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- 230000007850 degeneration Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53960504P | 2004-01-27 | 2004-01-27 | |
US61924104P | 2004-10-15 | 2004-10-15 | |
PCT/US2005/002996 WO2005072419A2 (fr) | 2004-01-27 | 2005-01-27 | Facteur proliferatif gastro-intestinal et utilisations de celui-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063522L true NO20063522L (no) | 2006-10-25 |
Family
ID=34830487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063522A NO20063522L (no) | 2004-01-27 | 2006-08-02 | Gastrointestinal proliferativ faktor og anvendelser derav |
Country Status (14)
Country | Link |
---|---|
US (4) | US20050256036A1 (fr) |
EP (1) | EP1727560B1 (fr) |
JP (1) | JP2007526248A (fr) |
KR (1) | KR20070007289A (fr) |
AU (1) | AU2005208945A1 (fr) |
BR (1) | BRPI0507168A (fr) |
CA (1) | CA2554403A1 (fr) |
IL (1) | IL177060A0 (fr) |
MX (1) | MXPA06008495A (fr) |
NO (1) | NO20063522L (fr) |
RU (2) | RU2343158C2 (fr) |
SG (1) | SG149059A1 (fr) |
TW (1) | TW200536859A (fr) |
WO (1) | WO2005072419A2 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE466106T1 (de) * | 2003-10-10 | 2010-05-15 | Deutsches Krebsforsch | Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen |
US20190330295A1 (en) * | 2005-05-04 | 2019-10-31 | Zealand Pharma A/S | Glucagon-like-peptide-2 (glp-2) analogues |
EP1942926A4 (fr) * | 2005-10-07 | 2010-06-16 | Nuvelo Inc | Scfa1, protéine du type facteur des cellules souches et utilisations de celle-ci |
CA2669693C (fr) | 2006-11-15 | 2018-06-12 | Massachusetts Eye & Ear Infirmary | Generation de cellules de l'oreille interne |
WO2008088524A2 (fr) * | 2006-12-28 | 2008-07-24 | Nuvelo, Inc. | Protéine r-spondine 1 à carence en domaines de thrombospondine utilisee en tant que facteur de prolifération épithéliale du tractus gastro-intestinal |
AU2008270972B2 (en) | 2007-07-02 | 2013-10-24 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
US9464275B2 (en) | 2008-08-21 | 2016-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Ex vivo culture, proliferation and expansion of intestinal epithelium |
AU2009316264B2 (en) * | 2008-11-24 | 2016-09-15 | Massachusetts Eye & Ear Infirmary | Pathways to generate hair cells |
US9752124B2 (en) | 2009-02-03 | 2017-09-05 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium for epithelial stem cells and organoids comprising the stem cells |
EP3061808B1 (fr) | 2009-02-03 | 2020-08-12 | Koninklijke Nederlandse Akademie van Wetenschappen | Milieu de culture de cellules souches épithéliales et organoïdes comprenant lesdites cellules souches |
EP2412800A1 (fr) | 2010-07-29 | 2012-02-01 | Koninklijke Nederlandse Akademie van Wetenschappen | Organoïde du foie, ses utilisations et son procédé de culture pour l'obtenir |
IT1396935B1 (it) | 2009-11-26 | 2012-12-20 | Solartium Entpr Ltd | Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici |
RU2532323C2 (ru) * | 2011-06-20 | 2014-11-10 | Мапикс Эс.Эй.Ар.Эл. | Лекарственное средство для лечения патологического синдрома и способ лечения функциональных нарушений кишечника |
GB201106395D0 (en) * | 2011-04-14 | 2011-06-01 | Hubrecht Inst | Compounds |
CN106167526A (zh) | 2011-07-15 | 2016-11-30 | 昂考梅德药品有限公司 | Rspo结合剂和其应用 |
AU2013289990B2 (en) | 2012-07-13 | 2018-06-14 | Oncomed Pharmaceuticals, Inc. | RSPO3 binding agents and uses thereof |
JP2015527398A (ja) | 2012-09-07 | 2015-09-17 | マサチューセッツ アイ アンド イヤー インファーマリー | 聴覚喪失治療 |
US10047134B2 (en) * | 2013-01-10 | 2018-08-14 | Biocon Limited | Process for expression of recombinant proteins in Pichia pastoris using a fed batch model |
WO2016022776A2 (fr) | 2014-08-06 | 2016-02-11 | Massachusetts Eye And Ear Infirmary | Augmentation de la durée de vie d'atoh1 pour diriger la différenciation des cellules ciliées neurosensorielles |
CA2961374A1 (fr) | 2014-09-16 | 2016-03-24 | Oncomed Pharmaceuticals, Inc. | Traitement de maladies fibrotiques |
JP6920203B2 (ja) * | 2015-01-30 | 2021-08-18 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill | 消化管上皮組織構築物を生成する方法 |
US11185536B2 (en) | 2015-12-04 | 2021-11-30 | Massachusetts Eye And Ear Infirmary | Treatment of hearing loss by inhibition of casein kinase 1 |
EP3943090A1 (fr) | 2016-01-29 | 2022-01-26 | Massachusetts Eye & Ear Infirmary | Expansion et différenciation des cellules de support de l'oreille interne, et méthodes d'utilisation de ces dernières |
US11180735B2 (en) | 2016-10-28 | 2021-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof |
WO2021247497A1 (fr) * | 2020-06-03 | 2021-12-09 | Children's Hospital Medical Center | Compositions et procédés comprenant des r-spondines pour le traitement de tumeurs |
JP2024519126A (ja) | 2021-05-21 | 2024-05-08 | エンブレーション リミテッド | 組織のマイクロ波治療 |
WO2023097236A1 (fr) * | 2021-11-24 | 2023-06-01 | The Rockefeller University | Compositions et procédés pour générer des souris knock-in d'immunoglobuline |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6824973B2 (en) * | 2000-02-03 | 2004-11-30 | Kirin Beer Kabushiki Kaisha | Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide |
AU5904101A (en) | 2000-04-05 | 2001-10-23 | Hyseq Inc | Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides |
US7411052B2 (en) * | 2001-03-05 | 2008-08-12 | Nuvelo, Inc. | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
US20030032034A1 (en) * | 2001-03-05 | 2003-02-13 | Tang Y. Tom | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
JP4208715B2 (ja) * | 2001-08-30 | 2009-01-14 | ヌヴェロ, インコーポレイテッド | 幹細胞増殖因子様ポリペプチドおよびポリヌクレオチドに関する方法および材料 |
EP1434796A2 (fr) | 2001-10-03 | 2004-07-07 | Incyte Genomics, Inc. | Proteines secretees |
WO2003054152A2 (fr) * | 2001-12-10 | 2003-07-03 | Nuvelo, Inc. | Nouveaux acides nucleiques et polypeptides |
US7193069B2 (en) * | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
WO2005110009A2 (fr) | 2003-07-22 | 2005-11-24 | Immunex Corporation | Compositions et methodes relatives aux tsp-30a, b, c et d |
WO2005032574A1 (fr) * | 2003-10-03 | 2005-04-14 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation de la proliferation de l'epithelium gastrointestinal par voie de signalisation wnt |
ATE466106T1 (de) * | 2003-10-10 | 2010-05-15 | Deutsches Krebsforsch | Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen |
-
2005
- 2005-01-27 US US11/046,644 patent/US20050256036A1/en not_active Abandoned
- 2005-01-27 KR KR1020067017297A patent/KR20070007289A/ko not_active Application Discontinuation
- 2005-01-27 EP EP05712439A patent/EP1727560B1/fr not_active Not-in-force
- 2005-01-27 MX MXPA06008495A patent/MXPA06008495A/es not_active Application Discontinuation
- 2005-01-27 SG SG200809511-9A patent/SG149059A1/en unknown
- 2005-01-27 WO PCT/US2005/002996 patent/WO2005072419A2/fr active Application Filing
- 2005-01-27 US US11/046,456 patent/US20050256044A1/en not_active Abandoned
- 2005-01-27 AU AU2005208945A patent/AU2005208945A1/en not_active Abandoned
- 2005-01-27 JP JP2006551541A patent/JP2007526248A/ja not_active Withdrawn
- 2005-01-27 BR BRPI0507168-2A patent/BRPI0507168A/pt not_active IP Right Cessation
- 2005-01-27 TW TW094102490A patent/TW200536859A/zh unknown
- 2005-01-27 RU RU2006130791/13A patent/RU2343158C2/ru active
- 2005-01-27 CA CA002554403A patent/CA2554403A1/fr not_active Abandoned
-
2006
- 2006-07-25 IL IL177060A patent/IL177060A0/en unknown
- 2006-08-02 NO NO20063522A patent/NO20063522L/no not_active Application Discontinuation
-
2007
- 2007-05-24 US US11/805,883 patent/US20080300183A1/en not_active Abandoned
-
2008
- 2008-09-09 RU RU2008136324/13A patent/RU2008136324A/ru not_active Application Discontinuation
-
2009
- 2009-10-27 US US12/589,727 patent/US7951381B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW200536859A (en) | 2005-11-16 |
EP1727560B1 (fr) | 2012-09-12 |
US7951381B2 (en) | 2011-05-31 |
MXPA06008495A (es) | 2007-05-23 |
WO2005072419A3 (fr) | 2007-06-28 |
BRPI0507168A (pt) | 2007-06-26 |
AU2005208945A1 (en) | 2005-08-11 |
EP1727560A2 (fr) | 2006-12-06 |
WO2005072419A2 (fr) | 2005-08-11 |
US20050256036A1 (en) | 2005-11-17 |
KR20070007289A (ko) | 2007-01-15 |
RU2008136324A (ru) | 2010-03-20 |
SG149059A1 (en) | 2009-01-29 |
RU2343158C2 (ru) | 2009-01-10 |
RU2006130791A (ru) | 2008-03-27 |
US20100137210A1 (en) | 2010-06-03 |
EP1727560A4 (fr) | 2009-09-09 |
IL177060A0 (en) | 2008-03-20 |
JP2007526248A (ja) | 2007-09-13 |
US20080300183A1 (en) | 2008-12-04 |
US20050256044A1 (en) | 2005-11-17 |
CA2554403A1 (fr) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063522L (no) | Gastrointestinal proliferativ faktor og anvendelser derav | |
IL219915A0 (en) | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases | |
NO20070049L (no) | Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
CL2007002578A1 (es) | Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer. | |
WO2008002621A3 (fr) | Effecteurs allostériques positifs du récepteur m1 à base de quinolone à substitution benzyle | |
EA201290322A1 (ru) | Лечение желудочно-кишечных расстройств | |
NO20075074L (no) | Kinazolinon T-type-kalsiumkanalantagonister | |
CL2008002954A1 (es) | Compuestos derivados de 1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahidrociclopenta-(5,6)nafto-(1,2-f)indazol heterociclo o carbociclo sustituido; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de asma, epoc, rinits alergica. | |
MY149492A (en) | Immunoglobulins directed against nogo | |
MX2010006388A (es) | Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina. | |
EA200970302A1 (ru) | Тиофенпиразолопиримидиновые соединения | |
TW200745081A (en) | Compounds | |
LU92202I9 (fr) | ||
GB0611907D0 (en) | Compounds | |
WO2006065600A3 (fr) | Derives de n-biaryl et de n-arylheteroaryl piperazine servant de modulateurs du recepteur 5ht2c utilises pour le traitement de troubles associes a celui-ci | |
WO2008013983A3 (fr) | Composés stabilisant les opsines et procédés d'utilisation | |
WO2006028492A3 (fr) | Hc1q/tnf7 et ses utilisations | |
GB0519760D0 (en) | Novel compounds | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
WO2008034909A3 (fr) | Traitement de seconde intention du cancer métastatique hormono-résistant de la prostate à l'aide de satraplatine | |
WO2006128120A3 (fr) | Nouveaux composes de lapachone et methodes d'utilisation | |
ZA200705349B (en) | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases | |
BRPI0419229A (pt) | derivados de tiofenopirimidinona substituìdos como inibidores de 17beta-hidroxiesteróide-desidrogenase, uso e composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |